These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19125944)

  • 41. [Gut flora and gut-derived endotoxin in minimal hepatic encephalopathy].
    Zhai HQ; Fan H; Geng JW; Tao J; Xun LT; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Feb; 22(2):104-7. PubMed ID: 24735591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.
    Jiang SM; Jia L; Zhang MH
    Int J Clin Exp Med; 2015; 8(6):9996-10000. PubMed ID: 26309689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
    Zhang Y; Feng Y; Cao B; Tian Q
    Int J Clin Exp Med; 2015; 8(2):2954-7. PubMed ID: 25932262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.
    Hanai T; Shiraki M; Watanabe S; Kochi T; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    Hepatol Res; 2017 Dec; 47(13):1359-1367. PubMed ID: 28199774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy.
    Shavakhi A; Hashemi H; Tabesh E; Derakhshan Z; Farzamnia S; Meshkinfar S; Shavakhi S; Minakari M; Gholamrezaei A
    J Res Med Sci; 2014 Aug; 19(8):703-8. PubMed ID: 25422653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
    Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
    Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
    Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis.
    Luo M; Li L; Yang EN; Cao WK
    Hepatol Res; 2012 Dec; 42(12):1202-10. PubMed ID: 22646055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients.
    Zuo Z; Fan H; Tang XD; Chen YM; Xun LT; Li Y; Song ZJ; Zhai HQ
    Exp Ther Med; 2017 Nov; 14(5):4887-4895. PubMed ID: 29201193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.
    Ridola L; Cardinale V; Riggio O
    Ann Gastroenterol; 2018; 31(2):151-164. PubMed ID: 29507462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
    Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
    Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
    Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy.
    Direkze S; Jalan R
    Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    Ishikawa T; Aibe Y; Matsuda T; Iwamoto T; Takami T; Sakaida I
    AJR Am J Roentgenol; 2017 Sep; 209(3):W169-W176. PubMed ID: 28657848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
    El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
    World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
    Vogels BA; Karlsen OT; Mass MA; Boveé WM; Chamuleau RA
    J Hepatol; 1997 Jan; 26(1):174-82. PubMed ID: 9148009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.